Australian-led mRNA cancer vaccine trial cuts melanoma return risk by 42 per cent

Australian scientists have led a world-first breakthrough in a personalised mRNA melanoma vaccine that is showing remarkable success.

NewsBeagle is a discovery engine. We show the headline, a short source-supplied summary and clear attribution. The complete reporting remains with the publisher.